Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Q: Paragraph: Researchers around the world are working to develop potential treatments or vaccines against the respiratory disease that has killed nearly 47,000 people and infected almost a million in just a few months. A team at the University of Pittsburgh School of Medicine in the United States said they were able to move quickly in developing a potential COVID-19 vaccine after working on other coronaviruses that cause Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS). “These two viruses, which are closely related to SARS-CoV-2 (the new coronavirus causing the COVID-19 pandemic), teach us that a particular protein, called a spike protein, is important for inducing immunity against the virus,” said Andrea Gambotto, an associate professor at Pittsburgh. “We knew exactly where to fight this new virus.”  When tested in mice, the prototype vaccine - which the researchers have called PittCoVacc - generated what they described as “a surge of antibodies” against the new coronavirus  within two weeks. The Pittsburgh researchers cautioned that because the animals have not been tracked for very long as yet, it is too early to say whether and for how long the immune response against COVID-19 lasts. But they said that in comparable tests in mice with their MERS experimental vaccine, a sufficient level of antibodies was produced to neutralize the virus for at least a year. So far, the antibody levels of the SARS-CoV-2 vaccinated animals seem to be following the same trend, they said in peer-reviewed study in the journal EBioMedicine. The team said they hope to start testing the vaccine candidate on people in clinical trials in the next few months. The potential vaccine uses a needle patch design, called a microneedle array, to increase its potential potency. This array is a fingertip-sized patch of 400 tiny needles made out of sugar and the spike protein, Gambotto explained. It is designed to deliver the spike protein pieces into the skin, where the immune reaction is strongest. Claim: Potential COVID-19 vaccine shows promise in mouse study.

A: Initial tests in mice of a potential COVID-19 vaccine delivered via a fingertip-sized patch have shown it can induce an immune response against the new coronavirus at levels that might prevent infection, U.S. scientists said on Thursday.
****
Q: Paragraph: But COVID-19 is shaking her views. The woman who would identify herself only as Stephanie, citing a fear of reprisals from committed anti-vaxxers, says she is now 50:50 on taking a vaccine should one be discovered for the respiratory disease caused by the new coronavirus. “I’ve definitely thought about it,” she told Reuters by phone from the United States, also expressing frustration at what she considers the anti-vax community’s downplaying of the pandemic’s seriousness. “We’re all being affected by this virus, schools closing, young people in hospital, and they still say it’s a hoax.”  As the world’s scientists and pharmaceutical companies seek a cure for the coronavirus, other anti-vaxxers are gearing up for a fight against any potential new vaccine. “Refuse, demonstrate,” said a Briton on Facebook in response to a post asking people how they would react if a vaccine was made mandatory. But some virologists say the quest for a vaccine is so widely supported that resistance will be eroded. The latest national surveys by pollster ORB International for the Vaccine Confidence Project (VCP), which monitors attitudes to immunisation, appear to support this idea. In France, where a 2018 poll showed one in three people did not view vaccines as safe, just 18% would refuse a coronavirus vaccine now, according to the VCP poll of around 1,000 people on March 18, a day after France locked down. In Australia, the VCP’s figure was also 7%, while Britain, where about 2,000 people were polled, and Austria registered 5% opposition in polls there a week later. “If a vaccine were made available tomorrow, everyone would jump to get it,” said Laurent-Henri Vignaud, who co-authored a history of France’s anti-vax movement. That view was challenged by Mary Holland, vice-chair of American non-profit group Children’s Health Defense, which is critical of vaccination in the United States. “I don’t think this virus fundamentally changes people’s deeply held concerns about vaccines,” she told Reuters. Although the term “anti-vax” is sometimes associated with conspiracy theories, many people are simply concerned about side-effects or industry ethics. Globally, one person in five does not view vaccines as safe or is unsure, according to a 2018 survey by the Wellcome Trust health fund. reut.rs/2JTb27q  In China, where the COVID-19 disease caused by the novel coronavirus originated, surveys by VCP researchers show safety is an important cause of concern. Several scandals eroded trust, including in 2018 when a unit of China’s vaccine maker Changsheng Bio-technology Co Ltd was heavily fined for falsifying data for a rabies vaccine. The company said it was “deeply sorry” for the incident. Online discussions tracked by Reuters - including closed Facebook pages with more than 200,000 members, Twitter feeds such as the Children’s Health Defense and YouTube videos totalling over 700,000 views - showed considerable mistrust that a rushed vaccine would be improperly tested. VCP director Heidi Larson said that was also the main reason for concern around the vaccine against the H1N1 swine flu pandemic in 2009. A quickly produced swine flu vaccine in 1976 led to about one in 100,000 people developing Guillain-Barre syndrome, a paralyzing immune-system disorder, according to the Center for Disease Control and Prevention (CDC). Some 115 coronavirus vaccine candidates are being developed by institutes and drugmakers, according to the Coalition for Epidemic Preparedness Innovation, a global alliance financing and coordinating the development of vaccines. “I will not be injected with anything, especially a fast-tracked vaccine,” added American Vicki Barneck, 67, who believes a strong immune system is enough to combat the disease. Holland, of the Children’s Health Defense, said: “Some react fine to vaccines, others are paralysed or killed.”   However, a 2015 paper by CDC epidemiologists said “multiple studies and scientific reviews have found no association between vaccination and deaths except in rare cases.”  The VCP is running an 18-month study tracking conversation online about the coronavirus and conducting global polls to measure attitudes towards social distancing, isolation, hand-washing and anticipating a vaccine. From analysing more than 3 million posts a day between January and mid-March 2020, director Dr Heidi Larson said the vast majority were eager for a treatment, fast. “People are hungry for a vaccine,” she said. In Italy, which has been hit badly by COVID-19, the anti-vax movement has “virtually disappeared” in the discussion on the coronavirus, according to virologist Dr Roberto Burioni. For a coronavirus vaccine to be effective, wide uptake and annual vaccination is likely to be required, said George Kassianos, immunisation lead at the Royal College of General Practitioners in London. There is also the question of how to distribute fast enough to people lining up for the vaccine. “Essential workers will be the priority. Police officers, hospital workers, cleaners. Then at-risk groups,” said Douglas L. Hatch, a physician specialised in pandemic preparedness working on the COVID-19 response in San Francisco. “By the time you get to the anti-vaxxers, they’ll have trouble getting it even if they wanted to.”  (Corrects French poll data in eighth paragraph) Claim: Could the new coronavirus weaken 'anti-vaxxers'?.

A: An American mother-of-three is a long-time member of “anti-vaxxer” groups online: a small but vocal global community that believes vaccines are a dangerous con and refuse to immunize themselves or their children.
****
Q: Paragraph: Not applicable. The cost of olive oil is not in question. This story did the best job of the three stories we reviewed in quantifying the potential benefits observed in the study. “Over the next five to six years, those intensive users suffered strokes at a rate of 0.3 percent per year. That compared with just over 0.5 percent among non-users, and 0.4 percent among moderate users. When the researchers factored in other diet habits, exercise levels and major risk factors for stroke — like high blood pressure and diabetes — heavy olive oil use was tied to 41 percent reduction in the odds of stroke.” There are better ways to try to communicate numbers of less than one percent. But we applaud the detail provided. Not applicable. Excellent. The story devoted almost 200 words to the potential limitations of such an observational study. Also a clear description of the cohort design. No disease-mongering of stroke in the story. The story included strong input from a researcher who wrote in an editorial on the study. The story at least mentioned other factors that could be at play – “no single food is consumed in isolation, he points out in his editorial. Olive oil is one part of the Mediterranean diet that has been tied to heart benefits. The diet also boasts plenty of fruits and vegetables, legumes, whole grains, fish and moderate amounts of red wine.” Not applicable. The availability of olive oil is not in question. The story attempted to put the new finding into the context of past research on olive oil and the Mediterranean diet. It’s clear the story did not rely on a news release. Claim: Olive oil lovers show lower stroke risk

A:
This story explored the nature of an observational study about the stroke-reducing risks of olive oil. The story appropriately discussed other possible reasons for the findings and why a clinical trial is stronger evidence. With so much news coverage touting an apparent benefit from olive oil in this study (CBS had a headline about “huge decline in stroke risk”), it is refreshing to see so much time and space given to a clear-eyed evaluation of the evidence as this story provided.
****